Firm Publications

Looking for more information about Dykema and/or one of our practice/industry areas? Many of our firm informational brochures are available online.

Michael Gzybowski authored the Intellectual Property Magazine article, “Covid costs,” which discusses how the pandemic has impacted R&D activity and patent filings. He provided examples of how R&D activities have been affected by pandemic-related issues, including the reduction in college and university support and mandated stay-at-home orders.

Marsha Gentner, Washington, D.C.-based Senior Counsel in Dykema’s Intellectual Property Group, authored the IP Watchdog article, “The Washington Football Team’s Trademark Journey:  Over the Bumps and Full Speed Ahead.”

Sean Griffin, Washington, D.C.-based Member in Dykema’s Litigation Practice, authored the Westlaw Today article, “Legal cybersecurity challenges of NFTs and ‘smart contracts.’”

Tania Shapiro-Barr, M.D., Minneapolis-based Member in Dykema’s Intellectual Property Practice Group, and Mark Mansour, Washington, D.C.-based Member in the firm’s Health Care Practice Group, co-authored the Intellectual Property Magazine article, “Avoiding a catch-22.”

Jimmy Azadian, Los Angeles- and Washington, D.C.-based Member in Dykema’s Litigation Practice and Co-Leader of the firm’s Appellate and Complex Motion Practice, co-authored the Orange County Lawyer article, “Proper Netiquette.”

Michael Gzybowski, Ann Arbor-based Senior Counsel in Dykema’s Intellectual Property practice group, authored the Bloomberg Law article, “Covid-19’s Impact on U.S. Patent Filings.”

Detroit-based attorneys, Rasul Raheem, Emphani Aldridge, and Monique Eubanks, along with San Antonio-based attorney Taylor Calvert, co-authored the ABA Banking Journal article, “Building Capacity of Lenders to the Underserved.”

Thomas Moga, Bloomfield Hills-based Senior Counsel in Dykema’s Intellectual Property Practice Group, authored the Intellectual Property Magazine article, “The treatment sprint.”

Thomas Moga, Bloomfield Hills-based Senior Counsel in Dykema’s Intellectual Property Practice Group, authored the Life Sciences Intellectual Property Review article, “The curious case of Wuhan’s Institute of Virology and remdesivir.”